According to introducing, this kind of EV71

Morning paper dispatch (reporter Xu Jingjing) yesterday, reporters learned that FMD vaccine phase 3 clinical trial results, vaccine can make the disease protection ratio reached 95%. This means that, once listed, has long vexed, foot and mouth disease children and parents will get effective control and prevention.

According to introducing, this kind of EV71 vaccine in phase III clinical study last year officially launched on January 6, successively has carried on the vaccine to 10000 infants and young children, completed a year-long epidemiological protection effect is observed. Results show that, for three consecutive batch of EV71 vaccine can at the age of 6 months to 5 people to produce good immune, and has good security. Hand, foot and mouth disease is an infectious disease common in infants, for hand, foot and mouth disease outbreak in summer. Because the kindergarten often outbreak, the vaccine requires two injection, under 6 years of age to play. The vaccine is expected to be listed in the second half of the year is approved. But has yet to study whether immunization, after its price will be priced reference price of 2 kinds of vaccine.